TransMedics Group Inc (TMDX)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 3.52 | 3.74 | 3.99 | 4.54 | 5.15 | 5.45 | 4.75 | 1.49 | 1.48 | 1.46 | 2.30 | 2.07 | 1.99 | 1.67 | 1.58 | 1.49 | 1.46 | 1.45 | 1.43 | 2.08 |
TransMedics Group Inc has shown a consistent and strong solvency position based on its solvency ratios. The Debt-to-assets ratio has remained at 0.00 throughout the reporting period, indicating that the company has not used debt to finance its assets. The Debt-to-capital ratio and Debt-to-equity ratio also stayed at 0.00 during this time frame, displaying the company's ability to fund its operations and investments without relying on debt.
The Financial leverage ratio, which evaluates the company's debt levels in relation to its equity, started at 2.08 in March 2020 and gradually decreased before experiencing a notable spike in June 2023 to 4.75. This increase may indicate a potential increase in debt relative to equity during that period. However, the ratio decreased in the subsequent periods, showing a positive trend towards managing the company's leverage.
Overall, TransMedics Group Inc has maintained a robust solvency position with minimal debt usage and a generally stable financial leverage ratio. Managing these ratios effectively can enhance the company's financial stability and ability to weather economic uncertainties.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 1.37 | 1.26 | 0.63 | -0.14 | -1.47 | -3.54 | -2.29 | -6.54 | -9.00 | -10.73 | -11.60 | -11.06 | -10.40 | -8.78 | -6.76 | -6.13 | -6.21 | -6.75 | -7.30 | -7.24 |
TransMedics Group Inc has shown a consistently negative trend in its interest coverage ratio from March 31, 2020, to September 30, 2022. The company's ability to cover its interest expenses with its operating income was worrying, with the ratio falling as low as -11.60 on June 30, 2022.
However, there has been a significant improvement in the interest coverage ratio from December 31, 2022, to December 31, 2024. The ratio turned positive by March 31, 2024, indicating that the company's operating income is now sufficient to cover its interest expenses. The positive trend continued, reaching 1.37 by December 31, 2024, signifying a more stable financial position in terms of meeting interest obligations.
Overall, the company has progressed from a precarious financial situation regarding interest coverage to a more secure position, showing improvement in its ability to meet its interest payment obligations.